Shandong Buchang Pharmaceutical Overview
- Year Founded
-
2001
- Status
-
Public
- Employees
-
7,237
- Stock Symbol
-
603858
- Investments
-
16
- Share Price
-
$2.23
- (As of Thursday Closing)
Shandong Buchang Pharmaceutical General Information
Description
Shandong Buchang Pharmaceuticals Co Ltd is engaged in research and development, production and sales of Chinese patent medicines.
Contact Information
Website
www.buchang.comCorporate Office
- Nanyang International Building
- Number 50 Gaoxin Road
- Xi'an, Shaanxi
- China
Corporate Office
- Nanyang International Building
- Number 50 Gaoxin Road
- Xi'an, Shaanxi
- China
Shandong Buchang Pharmaceutical Stock Performance
As of 12-Nov-2026, Shandong Buchang Pharmaceutical’s stock price is $2.23. Its current market cap is $2.35B with 1.05B shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $2.23 | $2.22 | $2.06 - $2.60 | $2.35B | 1.05B | 5.18M | $0.04 |
Shandong Buchang Pharmaceutical Financials Summary
As of 30-Sep-2026, Shandong Buchang Pharmaceutical has a trailing 12-month revenue of $1.66B.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 2,576,659 | 2,582,339 | 2,689,074 | 2,937,992 |
| Revenue | 1,657,381 | 1,651,298 | 1,533,810 | 1,872,135 |
| EBITDA | 82,743 | 161,601 | 52,274 | 152,404 |
| Net Income | 40,888 | 50,169 | (77,179) | 45,085 |
| Total Assets | 2,844,792 | 2,750,541 | 2,647,705 | 2,947,309 |
| Total Debt | 548,868 | 514,567 | 499,150 | 444,622 |
Shandong Buchang Pharmaceutical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Shandong Buchang Pharmaceutical Patents
Shandong Buchang Pharmaceutical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3175596-A1 | Traditional chinese medicine for dispersing lung qi and detoxicating | Pending | 07-Apr-2020 | ||
| US-20230113539-A1 | Traditional chinese medicine for dispersing lung qi and detoxicating | Pending | 07-Apr-2020 | ||
| WO-2021203933-A1 | Traditional chinese medicine for dispersing lung qi and detoxication | Inactive | 07-Apr-2020 | A61P11/00 |
Shandong Buchang Pharmaceutical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Shandong Buchang Pharmaceutical Investments & Acquisitions (16)
Shandong Buchang Pharmaceutical’s most recent deal was a Joint Venture with Hepu Tongchuang Medical. The deal was made on 20-May-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Hepu Tongchuang Medical | 20-May-2026 | Joint Venture | Distributors (Healthcare) | ||
| Changrui Bio | 20-Sep-2023 | Secondary Transaction - Private | Drug Discovery | ||
| Changrui Bio | 10-Mar-2023 | Merger/Acquisition | Drug Discovery | ||
| Hunan Zhongce | 08-Nov-2021 | Merger/Acquisition | Other Devices and Supplies | ||
| Beijing Chengrui | 01-Nov-2021 | Merger/Acquisition | Diagnostic Equipment |
Shandong Buchang Pharmaceutical ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
45.12 | Severe Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Shandong Buchang Pharmaceutical Exits (3)
Shandong Buchang Pharmaceutical’s most recent exit was on 08-Nov-2021 from Hunan Zhongce. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Hunan Zhongce | 08-Nov-2021 | Completed |
|
||
| Kfyao | 18-Apr-2017 | Completed |
|
||
| PomDoctor | 06-Nov-2015 | Later Stage VC | Completed |
Shandong Buchang Pharmaceutical Affiliates
Subsidiaries (5)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Changrui Bio | Chengdu, China | 2021 | |
| Beijing Chengrui | Beijing, China | 2020 | |
| Qionglai Tianyin | Qionglai, China | 2014 | |
| Luzhou Buchang Biopharmaceutical | Luzhou, China | 2014 | |
| Tonghua Guhong | Jilin, China | 2012 |
Shandong Buchang Pharmaceutical FAQs
-
When was Shandong Buchang Pharmaceutical founded?
Shandong Buchang Pharmaceutical was founded in 2001.
-
Where is Shandong Buchang Pharmaceutical headquartered?
Shandong Buchang Pharmaceutical is headquartered in Xi'an, China.
-
What is the size of Shandong Buchang Pharmaceutical?
Shandong Buchang Pharmaceutical has 7,237 total employees.
-
What industry is Shandong Buchang Pharmaceutical in?
Shandong Buchang Pharmaceutical’s primary industry is Pharmaceuticals.
-
Is Shandong Buchang Pharmaceutical a private or public company?
Shandong Buchang Pharmaceutical is a Public company.
-
What is Shandong Buchang Pharmaceutical’s stock symbol?
The ticker symbol for Shandong Buchang Pharmaceutical is 603858.
-
What is the current stock price of Shandong Buchang Pharmaceutical?
As of 12-Nov-2026 the stock price of Shandong Buchang Pharmaceutical is $2.23.
-
What is the current market cap of Shandong Buchang Pharmaceutical?
The current market capitalization of Shandong Buchang Pharmaceutical is $2.35B.
-
What is Shandong Buchang Pharmaceutical’s current revenue?
The trailing twelve month revenue for Shandong Buchang Pharmaceutical is $1.66B.
-
What is Shandong Buchang Pharmaceutical’s annual earnings per share (EPS)?
Shandong Buchang Pharmaceutical’s EPS for 12 months was $0.04.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
